Temat: "Carcinoma" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Combination of Osimertinib and Olaparib Therapy to Treat Non-Small Cell Lung Cancer and High-Grade Serous Ovarian Carcinoma: A Case Report.
Autorzy:: Lin J; Schulich School of Medicine & Dentistry, Western University, London, ON N6A 3K7, Canada.
Welch S; Division of Medical Oncology, Department of Oncology, Western University, London, ON N6A 3K7, Canada.
Sanatani M; Division of Medical Oncology, Department of Oncology, Western University, London, ON N6A 3K7, Canada.
Ramadan S; Postgraduate Medical Education, Department of Oncology, Western University, London, ON N6A 3K7, Canada.; Pokaż więcej
Źródło:: Current oncology (Toronto, Ont.) [Curr Oncol] 2024 Jan 19; Vol. 31 (1), pp. 558-565. Date of Electronic Publication: 2024 Jan 19.
Typ publikacji:: Case Reports
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Ovarian Neoplasms*/drug therapy
Ovarian Neoplasms*/genetics
Ovarian Neoplasms*/pathology
Phthalazines*
Piperazines*
Acrylamides*
Aniline Compounds*
Indoles*
Pyrimidines*
Female ; Humans ; Aged ; Carcinoma, Ovarian Epithelial

Raport

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Role of eosinophilia in patients with recurrent/metastatic head and neck squamous cell carcinoma treated with nivolumab: Prediction of immune-related adverse events and favorable outcome.
Autorzy:: Ueki Y; Department of Otolaryngology Head and Neck Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Ohshima S; Department of Otolaryngology Head and Neck Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Omata J; Department of Otolaryngology Head and Neck Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Yokoyama Y; Department of Otolaryngology Head and Neck Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Takahashi T; Department of Otolaryngology Head and Neck Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Shodo R; Department of Otolaryngology Head and Neck Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Yamazaki K; Department of Otolaryngology Head and Neck Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Horii A; Department of Otolaryngology Head and Neck Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.; Pokaż więcej
Źródło:: Cancer medicine [Cancer Med] 2023 Nov; Vol. 12 (22), pp. 20810-20820. Date of Electronic Publication: 2023 Oct 30.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/pathology
Antineoplastic Agents, Immunological*/adverse effects
Eosinophilia*
Head and Neck Neoplasms*/drug therapy
Humans ; Nivolumab/adverse effects ; Squamous Cell Carcinoma of Head and Neck/drug therapy ; Squamous Cell Carcinoma of Head and Neck/chemically induced ; Neoplasm Recurrence, Local/drug therapy ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Efficacy of neoadjuvant immunochemotherapy and survival surrogate analysis of neoadjuvant treatment in IB-IIIB lung squamous cell carcinoma.
Autorzy:: Liu J; Department of Thoracic Surgery, The First Affiliated Hospital, School of Medicine, Zhejiang University, No. 79 Qingchun Road, Hangzhou, 310003, China.
Zhu L; Department of Thoracic Surgery, The First Affiliated Hospital, School of Medicine, Zhejiang University, No. 79 Qingchun Road, Hangzhou, 310003, China. Linhai_.
Tang M; Department of Thoracic Surgery, The First Affiliated Hospital, School of Medicine, Zhejiang University, No. 79 Qingchun Road, Hangzhou, 310003, China.
Huang X; Department of Thoracic Surgery, The First Affiliated Hospital, School of Medicine, Zhejiang University, No. 79 Qingchun Road, Hangzhou, 310003, China.
Gu C; Department of Thoracic Surgery, The First Affiliated Hospital, School of Medicine, Zhejiang University, No. 79 Qingchun Road, Hangzhou, 310003, China.
He C; Department of Thoracic Surgery, The First Affiliated Hospital, School of Medicine, Zhejiang University, No. 79 Qingchun Road, Hangzhou, 310003, China.
Lv X; Department of Thoracic Surgery, The First Affiliated Hospital, School of Medicine, Zhejiang University, No. 79 Qingchun Road, Hangzhou, 310003, China. .
Hu J; Department of Thoracic Surgery, The First Affiliated Hospital, School of Medicine, Zhejiang University, No. 79 Qingchun Road, Hangzhou, 310003, China. dr_.; Key Laboratory of Clinical Evaluation Technology for Medical Device of Zhejiang Province, Hangzhou, 310003, China. dr_.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Mar 06; Vol. 14 (1), pp. 5523. Date of Electronic Publication: 2024 Mar 06.
Typ publikacji:: Controlled Clinical Trial; Journal Article
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*
Carcinoma, Squamous Cell*/drug therapy
Lung Neoplasms*/drug therapy
Humans ; Lung ; Neoadjuvant Therapy ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: The insufficiency of CT examination in early detection of central lung squamous cell carcinoma and squamous epithelial precancerous lesions.
Autorzy:: Zhou J; Department of Endoscopy, Zhejiang Cancer Hospital, Hangzhou, China.
Yu B; Department of Endoscopy, Zhejiang Cancer Hospital, Hangzhou, China.
Guo P; Department of Endoscopy, Zhejiang Cancer Hospital, Hangzhou, China.
Wang S; Department of Endoscopy, Zhejiang Cancer Hospital, Hangzhou, China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2024 Mar 05; Vol. 24 (1), pp. 299. Date of Electronic Publication: 2024 Mar 05.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*
Carcinoma, Squamous Cell*/diagnostic imaging
Lung Neoplasms*/diagnostic imaging
Precancerous Conditions*/diagnostic imaging
Aged ; Female ; Middle Aged ; Humans ; Male ; Lymphatic Metastasis ; Retrospective Studies ; Early Detection of Cancer ; Lung

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Neuroendocrine and squamous cell phenotypes of NUT carcinoma are potential diagnostic pitfalls that discriminating it from mimickers, such as small cell and squamous cell carcinoma.
Autorzy:: Ninomiya H; Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan. .; Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan. .
Sato Y; Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.; Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Inamura K; Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.; Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Dobashi A; Pathology Project for Molecular Targets, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.
Takeuchi K; Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.; Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.; Pathology Project for Molecular Targets, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.
Mitani H; Division of Head and Neck Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Mun M; Thoracic Surgical Oncology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Nishio M; Thoracic Medical Oncology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Ishikawa Y; Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.; Department of Pathology, Mita Hospital, International University of Health and Welfare, Tokyo, Japan.; Pokaż więcej
Źródło:: Diagnostic pathology [Diagn Pathol] 2024 Feb 07; Vol. 19 (1), pp. 27. Date of Electronic Publication: 2024 Feb 07.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Squamous Cell*/pathology
Small Cell Lung Carcinoma*
Lung Neoplasms*/pathology
Carcinoma, Neuroendocrine*/pathology
Humans ; Biomarkers, Tumor/analysis ; Synaptophysin/analysis ; Epithelial Cells/pathology ; Phenotype ; Repressor Proteins/analysis

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: A very rare case of spontaneous regression of basaloid squamous cell carcinoma of the lung.
Autorzy:: Koike S; Department of Thoracic Surgery, Ina Central Hospital, Nagano, Japan.; Division of General Thoracic Surgery, Department of Surgery, Shinshu University School of Medicine, Nagano, Japan.
Shiina T; Department of Thoracic Surgery, Ina Central Hospital, Nagano, Japan.
Takasuna K; Department of Thoracic Surgery, Ina Central Hospital, Nagano, Japan.
Kato A; Department of Respirology, Ina Central Hospital, Nagano, Japan.
Atagi T; Department of Respirology, Ina Central Hospital, Nagano, Japan.
Nakamura T; Department of Pathology, Ina Central Hospital, Nagano, Japan.; Pokaż więcej
Źródło:: Thoracic cancer [Thorac Cancer] 2024 Feb; Vol. 15 (6), pp. 500-502. Date of Electronic Publication: 2024 Jan 13.
Typ publikacji:: Case Reports
MeSH Terms:: Lung Neoplasms*/pathology
Carcinoma, Non-Small-Cell Lung*
Carcinoma, Squamous Cell*/surgery
Carcinoma, Squamous Cell*/pathology
Male ; Humans ; Aged ; Remission, Spontaneous ; Lung/pathology

Raport

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Comparison of early patient-reported outcomes between uniportal thoracoscopic segmentectomy and wedge resection for peripheral small-sized non-small-cell lung cancer.
Autorzy:: Zhao Y; Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, 610041, Sichuan, China.
Liu W; Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, 610041, Sichuan, China.
Gao X; Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, 610041, Sichuan, China.
Zhang K; Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Graduate School, Chengdu Medical college, Chengdu, 610041, Sichuan, China.
Dai W; Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, 610041, Sichuan, China.
Wei X; Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, 610041, Sichuan, China.
Zheng H; Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, 610041, Sichuan, China.
Lei C; School of Public Health, Chongqing Medical University, Chongqing, 400016, China.
Yu H; State Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University, Chongqing, 400016, China.
Shi Q; Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, 610041, Sichuan, China.; School of Public Health, Chongqing Medical University, Chongqing, 400016, China.; State Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University, Chongqing, 400016, China.
Li Q; Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, 610041, Sichuan, China.
Xie T; Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, 610041, Sichuan, China. .; Pokaż więcej
Źródło:: Journal of cardiothoracic surgery [J Cardiothorac Surg] 2024 Apr 15; Vol. 19 (1), pp. 215. Date of Electronic Publication: 2024 Apr 15.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/surgery
Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/surgery
Lung Neoplasms*/pathology
Humans ; Aftercare ; Neoplasm Staging ; Patient Discharge ; Pneumonectomy/methods ; Prospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: ESCO2's oncogenic role in human tumors: a pan-cancer analysis and experimental validation.
Autorzy:: Huang Y; Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.
Chen D; Tianjin First Central Hospital Clinic Institute, Tianjin Medical University, Tianjin, 300192, China.
Bai Y; Department of Hepatobiliary Surgery, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, 300192, China.
Zhang Y; Department of Hepatobiliary Surgery, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, 300192, China.
Zheng Z; Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.
Fu Q; Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.
Yi B; Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.
Jiang Y; Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.
Zhang Z; Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China. .
Zhu J; Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2024 Apr 11; Vol. 24 (1), pp. 452. Date of Electronic Publication: 2024 Apr 11.
Typ publikacji:: Journal Article
MeSH Terms:: Adenocarcinoma*
Colonic Neoplasms*
Pancreatic Neoplasms*
Carcinoma, Hepatocellular*
Carcinoma, Renal Cell*/genetics
Adenocarcinoma of Lung*
Thymus Neoplasms*
Liver Neoplasms*
Kidney Neoplasms*
Lung Neoplasms*
Adrenal Cortex Neoplasms*
Humans ; Acetyltransferases ; Chromosomal Proteins, Non-Histone

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Machine learning for differentiating lung squamous cell cancer from adenocarcinoma using Clinical-Metabolic characteristics and 18F-FDG PET/CT radiomics.
Autorzy:: Zhang Y; Department of Radiation Oncology, The Third Affillated Teaching Hospital of Xinjiang Medical University, Affilated Cancer Hospital, Urumuqi, China.; Xinjiang Key Laboratory of Oncology, Urumqi, China.
Liu H; Department of Radiation Oncology, Binzhou People's Hospital, Binzhou, China.
Chang C; Department of Nuclear Medicine, The Third Affillated Teaching Hospital of Xinjiang Medical University, Affilated Cancer Hospital, Urumuqi, China.
Yin Y; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
Wang R; Department of Radiation Oncology, The Third Affillated Teaching Hospital of Xinjiang Medical University, Affilated Cancer Hospital, Urumuqi, China.; Xinjiang Key Laboratory of Oncology, Urumqi, China.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2024 Apr 03; Vol. 19 (4), pp. e0300170. Date of Electronic Publication: 2024 Apr 03 (Print Publication: 2024).
Typ publikacji:: Randomized Controlled Trial; Journal Article
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/diagnostic imaging
Lung Neoplasms*/diagnostic imaging
Adenocarcinoma*/diagnostic imaging
Carcinoma, Squamous Cell*/diagnostic imaging
Humans ; Positron Emission Tomography Computed Tomography ; Fluorodeoxyglucose F18 ; Radiomics ; Retrospective Studies ; Machine Learning ; Epithelial Cells ; Lung

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Efficacy of second-line chemotherapy in patients with pulmonary large cell neuroendocrine carcinoma.
Autorzy:: Iida Y; Division of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan.; Division of Respiratory Medicine, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan.
Wakuda K; Division of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan.
Kenmotsu H; Division of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan. .
Doshita K; Division of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan.
Kodama H; Division of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan.
Nishioka N; Division of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan.
Miyawaki E; Division of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan.
Miyawaki T; Division of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan.
Mamesaya N; Division of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan.
Kobayashi H; Division of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan.
Omori S; Division of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan.; Respiratory Medicine and Infectious Diseases, Oita University Faculty of Medicine, Oita, Japan.
Ko R; Division of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan.
Ono A; Division of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan.
Naito T; Division of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan.
Murakami H; Division of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan.
Sugino T; Division of Pathology, Shizuoka Cancer Center, Shizuoka, Japan.
Gon Y; Division of Respiratory Medicine, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan.
Takahashi T; Division of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Apr 01; Vol. 14 (1), pp. 7641. Date of Electronic Publication: 2024 Apr 01.
Typ publikacji:: Journal Article
MeSH Terms:: Lung Neoplasms*/pathology
Small Cell Lung Carcinoma*/pathology
Carcinoma, Large Cell*/drug therapy
Carcinoma, Large Cell*/pathology
Carcinoma, Neuroendocrine*/pathology
Humans ; Retrospective Studies ; Anthracyclines/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Six-Gene Signature for Differential Diagnosis and Therapeutic Decisions in Non-Small-Cell Lung Cancer-A Validation Study.
Autorzy:: Charkiewicz R; Center of Experimental Medicine, Medical University of Bialystok, 15-369 Bialystok, Poland.; Department of Clinical Molecular Biology, Medical University of Bialystok, 15-269 Bialystok, Poland.
Sulewska A; Department of Clinical Molecular Biology, Medical University of Bialystok, 15-269 Bialystok, Poland.
Karabowicz P; Biobank, Medical University of Bialystok, 15-269 Bialystok, Poland.
Lapuc G; Department of Thoracic Surgery, Medical University of Bialystok, 15-269 Bialystok, Poland.
Charkiewicz A; Department of Analysis and Bioanalysis of Medicines, Medical University of Bialystok, 15-089 Bialystok, Poland.
Kraska M; Department of Clinical Molecular Biology, Medical University of Bialystok, 15-269 Bialystok, Poland.; Department of Medical Pathomorphology, Medical University of Bialystok, 15-269 Bialystok, Poland.
Pancewicz J; Department of Histology and Embryology, Medical University of Bialystok, 15-269 Bialystok, Poland.
Lukasik M; Department of Histology and Embryology, Medical University of Bialystok, 15-269 Bialystok, Poland.
Kozlowski M; Department of Thoracic Surgery, Medical University of Bialystok, 15-269 Bialystok, Poland.
Stec R; Department of Oncology, Medical University of Warsaw, 02-091 Warsaw, Poland.
Ziembicka D; Department of Public Health, Medical University of Bialystok, 15-295 Bialystok, Poland.
Piszcz W; Department of Clinical Molecular Biology, Medical University of Bialystok, 15-269 Bialystok, Poland.
Miltyk W; Department of Analysis and Bioanalysis of Medicines, Medical University of Bialystok, 15-089 Bialystok, Poland.
Niklinska W; Department of Histology and Embryology, Medical University of Bialystok, 15-269 Bialystok, Poland.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Mar 23; Vol. 25 (7). Date of Electronic Publication: 2024 Mar 23.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/diagnosis
Carcinoma, Non-Small-Cell Lung*/genetics
Carcinoma, Non-Small-Cell Lung*/therapy
Lung Neoplasms*/diagnosis
Lung Neoplasms*/genetics
Lung Neoplasms*/therapy
Adenocarcinoma*
Carcinoma, Squamous Cell*/diagnosis
Carcinoma, Squamous Cell*/genetics
Carcinoma, Squamous Cell*/therapy
Small Cell Lung Carcinoma*
Humans ; Diagnosis, Differential

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Auranofin repurposing for lung and pancreatic cancer: low CA12 expression as a marker of sensitivity in patient-derived organoids, with potentiated efficacy by AKT inhibition.
Autorzy:: Deben C; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Wilrijk, Belgium. .
Boullosa LF; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Wilrijk, Belgium.
Fortes FR; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Wilrijk, Belgium.
De La Hoz EC; Industrial Vision Lab, University of Antwerp, Wilrijk, Belgium.
Le Compte M; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Wilrijk, Belgium.
Seghers S; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Wilrijk, Belgium.
Peeters M; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Wilrijk, Belgium.
Vanlanduit S; Industrial Vision Lab, University of Antwerp, Wilrijk, Belgium.
Lin A; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Wilrijk, Belgium.; Plasma Lab for Applications in Sustainability and Medicine ANTwerp (PLASMANT), University of Antwerp, Wilrijk, Belgium.
Dijkstra KK; Department of Molecular Oncology and Immunology, the Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.
Van Schil P; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Wilrijk, Belgium.; Department of Thoracic and Vascular Surgery, Antwerp University Hospital, Edegem, Belgium.
Hendriks JMH; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Wilrijk, Belgium.; Department of Thoracic and Vascular Surgery, Antwerp University Hospital, Edegem, Belgium.
Prenen H; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Wilrijk, Belgium.; Department of Oncology, Multidisciplinary Oncological Center Antwerp, Antwerp University Hospital, Antwerp, Belgium.
Roeyen G; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Wilrijk, Belgium.; Department of Hepatobiliary Transplantation and Endocrine Surgery, University Hospital Antwerp (UZA), Edegem, Belgium.
Lardon F; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Wilrijk, Belgium.
Smits E; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Wilrijk, Belgium.; Center for Cell Therapy and Regenerative Medicine, Antwerp University Hospital, Edegem, Belgium.; Pokaż więcej
Źródło:: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2024 Mar 22; Vol. 43 (1), pp. 88. Date of Electronic Publication: 2024 Mar 22.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/genetics
Pancreatic Neoplasms*/pathology
Carcinoma, Pancreatic Ductal*/drug therapy
Adenocarcinoma*/drug therapy
Antineoplastic Agents*/pharmacology
Antineoplastic Agents*/therapeutic use
Carbonic Anhydrases*
Humans ; Auranofin/pharmacology ; Auranofin/therapeutic use ; Proto-Oncogene Proteins c-akt/metabolism ; Drug Repositioning ; Lung/pathology ; Biomarkers ; Organoids/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Prediction uncertainty estimates elucidate the limitation of current NSCLC subtype classification in representing mutational heterogeneity.
Autorzy:: Puiu A; Advanta, Siemens SRL, Brasov, 500007, Romania.; Automation and Information Technology, Transilvania University of Brasov, Brasov, 500174, Romania.
Gómez Tapia C; Digital Technology and Innovation, Siemens Healthineers, Erlangen, 91052, Germany.
Weiss MER; Digital Technology and Innovation, Siemens Healthineers, Erlangen, 91052, Germany.
Singh V; Digital Technology and Innovation, Siemens Healthineers, Princeton, 08540, USA.
Kamen A; Digital Technology and Innovation, Siemens Healthineers, Princeton, 08540, USA.
Siebert M; Digital Technology and Innovation, Siemens Healthineers, Erlangen, 91052, Germany. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Mar 21; Vol. 14 (1), pp. 6779. Date of Electronic Publication: 2024 Mar 21.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/pathology
Carcinoma, Squamous Cell*/pathology
Humans ; Uncertainty ; Mutation

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Population Survival Kinetics Derived from Clinical Trials of Potentially Curable Lung Cancers.
Autorzy:: Stewart DJ; Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON K1H 8L6, Canada.
Cole K; Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON K1H 8L6, Canada.; Department of Epidemiology and Biostatistics, University of California, San Francisco, CA 94143, USA.
Bosse D; Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON K1H 8L6, Canada.
Brule S; Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON K1H 8L6, Canada.
Fergusson D; Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON K1H 8L6, Canada.
Ramsay T; Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON K1H 8L6, Canada.; Pokaż więcej
Źródło:: Current oncology (Toronto, Ont.) [Curr Oncol] 2024 Mar 20; Vol. 31 (3), pp. 1600-1617. Date of Electronic Publication: 2024 Mar 20.
Typ publikacji:: Journal Article
MeSH Terms:: Lung Neoplasms*/drug therapy
Carcinoma, Non-Small-Cell Lung*/drug therapy
Small Cell Lung Carcinoma*
Acrylamides*
Aniline Compounds*
Indoles*
Pyrimidines*
Humans ; Neoplasm Staging ; Neoplasm Recurrence, Local ; Recurrence

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Biomarker Turnaround Times and Impact on Treatment Decisions in Patients with Advanced Non-Small Cell Lung Carcinoma at a Large Canadian Community Hospital with an Affiliated Regional Cancer Centre.
Autorzy:: Fleming KE; Office of Innovation & Research, Grand River Hospital, Kitchener, ON N2G 1G3, Canada.
Hupel A; Office of Innovation & Research, Grand River Hospital, Kitchener, ON N2G 1G3, Canada.
Mithoowani H; Department of Oncology, London Health Sciences Centre, London, ON N6A 5W9, Canada.
Lulic-Kuryllo T; Office of Innovation & Research, Grand River Hospital, Kitchener, ON N2G 1G3, Canada.
Valdes M; Department of Oncology, Grand River Regional Cancer Centre, Kitchener, ON N2G 1G3, Canada.; Pokaż więcej
Źródło:: Current oncology (Toronto, Ont.) [Curr Oncol] 2024 Mar 14; Vol. 31 (3), pp. 1515-1528. Date of Electronic Publication: 2024 Mar 14.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/drug therapy
Lung Neoplasms*/drug therapy
Carcinoma, Squamous Cell*/pathology
Humans ; Retrospective Studies ; Hospitals, Community ; Quality of Life ; Biomarkers, Tumor/metabolism ; Canada

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Surgery for pulmonary lesions in patients with a history of urinary tract transitional cell carcinoma.
Autorzy:: Kanzaki R; Department of General Thoracic Surgery, Osaka University Graduate School of Medicine, L5-2-2 Yamadaoka, Suita-City, Osaka, 565-0871, Japan. .
Nagoya A; Department of General Thoracic Surgery, Osaka University Graduate School of Medicine, L5-2-2 Yamadaoka, Suita-City, Osaka, 565-0871, Japan.
Taniguchi S; Department of General Thoracic Surgery, Osaka University Graduate School of Medicine, L5-2-2 Yamadaoka, Suita-City, Osaka, 565-0871, Japan.
Ishida H; Department of General Thoracic Surgery, Osaka University Graduate School of Medicine, L5-2-2 Yamadaoka, Suita-City, Osaka, 565-0871, Japan.
Kimura K; Department of General Thoracic Surgery, Osaka University Graduate School of Medicine, L5-2-2 Yamadaoka, Suita-City, Osaka, 565-0871, Japan.
Fukui E; Department of General Thoracic Surgery, Osaka University Graduate School of Medicine, L5-2-2 Yamadaoka, Suita-City, Osaka, 565-0871, Japan.
Kimura T; Department of General Thoracic Surgery, Osaka University Graduate School of Medicine, L5-2-2 Yamadaoka, Suita-City, Osaka, 565-0871, Japan.
Kanou T; Department of General Thoracic Surgery, Osaka University Graduate School of Medicine, L5-2-2 Yamadaoka, Suita-City, Osaka, 565-0871, Japan.
Ose N; Department of General Thoracic Surgery, Osaka University Graduate School of Medicine, L5-2-2 Yamadaoka, Suita-City, Osaka, 565-0871, Japan.
Funaki S; Department of General Thoracic Surgery, Osaka University Graduate School of Medicine, L5-2-2 Yamadaoka, Suita-City, Osaka, 565-0871, Japan.
Minami M; Department of General Thoracic Surgery, Osaka University Graduate School of Medicine, L5-2-2 Yamadaoka, Suita-City, Osaka, 565-0871, Japan.
Morii E; Department of Pathology, Osaka University Graduate School of Medicine, Suita, Japan.
Shintani Y; Department of General Thoracic Surgery, Osaka University Graduate School of Medicine, L5-2-2 Yamadaoka, Suita-City, Osaka, 565-0871, Japan.; Pokaż więcej
Źródło:: Journal of cardiothoracic surgery [J Cardiothorac Surg] 2024 Mar 12; Vol. 19 (1), pp. 117. Date of Electronic Publication: 2024 Mar 12.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Transitional Cell*/pathology
Carcinoma, Transitional Cell*/surgery
Lung Neoplasms*/surgery
Urinary Tract*/pathology
Humans ; Male ; Female ; Aged ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Cost-effectiveness of immunotherapies for advanced squamous non-small cell lung cancer: a systematic review.
Autorzy:: Cheng M; Department of Pharmacy, Zhejiang Hospital, 310013, Hangzhou, China.
Shao Y; Department of Pharmacy, Zhejiang Provincial People's Hospital, 310014, Hangzhou, China.
Li L; Department of Pharmacy, Zhejiang Hospital, 310013, Hangzhou, China.
Jiang M; Zhejiang Center of Drug and Cosmetics Evaluation, 310000, Hangzhou, Zhejiang, China.
Song Z; Department of Pharmacy, Zhejiang Hospital, 310013, Hangzhou, China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2024 Mar 06; Vol. 24 (1), pp. 312. Date of Electronic Publication: 2024 Mar 06.
Typ publikacji:: Systematic Review; Journal Article
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/drug therapy
Lung Neoplasms*/drug therapy
Carcinoma, Squamous Cell*/drug therapy
Humans ; Cost-Benefit Analysis ; Cost-Effectiveness Analysis ; Immunotherapy

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: A retrospective analysis of optimal timing of thoracic radiotherapy for driver gene-negative metastatic non-small cell lung cancer.
Autorzy:: Wang Y; Department of Radiation Oncology, Shandong University Cancer Center, Jinan, China.; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
Gao Z; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
Zhao W; Department of Medical Oncology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Li H; School of Pharmacy, Shandong University, Jinan, China.
Meng X; Department of Radiation Oncology, Shandong University Cancer Center, Jinan, China.; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
Li J; Department of Medical Oncology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.; Pokaż więcej
Źródło:: Thoracic cancer [Thorac Cancer] 2024 Mar; Vol. 15 (8), pp. 642-653. Date of Electronic Publication: 2024 Feb 07.
Typ publikacji:: Journal Article
MeSH Terms:: Lung Neoplasms*/genetics
Lung Neoplasms*/radiotherapy
Small Cell Lung Carcinoma*/pathology
Carcinoma, Non-Small-Cell Lung*/genetics
Carcinoma, Non-Small-Cell Lung*/radiotherapy
Carcinoma, Non-Small-Cell Lung*/pathology
Humans ; Retrospective Studies ; Treatment Outcome ; Neoplasm Staging

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Prognostic implications of neutrophil-to-lymphocyte ratio in patients with extensive-stage small cell lung cancer receiving chemoimmunotherapy: A multicenter, real-world study.
Autorzy:: Bi H; Department of Respiratory and Critical Care Medicine, the Affiliated Hospital of Qingdao University, Qingdao, China.; Department of Respiratory and Critical Care Medicine, The Affiliated Qingdao Central Hospital of Medical College of Qingdao University, Qingdao, China.
Ren D; Department of Respiratory and Critical Care Medicine, the Affiliated Hospital of Qingdao University, Qingdao, China.
Xiao Y; Department of Respiratory and Critical Care Medicine, the Affiliated Hospital of Qingdao University, Qingdao, China.
Zhou Y; Department of Respiratory and Critical Care Medicine, the Affiliated Hospital of Qingdao University, Qingdao, China.
Yi B; Department of Respiratory and Critical Care Medicine, the Affiliated Hospital of Qingdao University, Qingdao, China.
Han W; Department of Respiratory and Critical Care Medicine, the Affiliated Hospital of Qingdao University, Qingdao, China.
Shao Y; Department of Respiratory and Critical Care Medicine, the Affiliated Hospital of Qingdao University, Qingdao, China.
Wang J; Department of Respiratory and Critical Care Medicine, the Affiliated Hospital of Qingdao University, Qingdao, China.
Zhang C; Department of Respiratory and Critical Care Medicine, The Affiliated Qingdao Central Hospital of Medical College of Qingdao University, Qingdao, China.
Wang H; Department of Respiratory and Critical Care Medicine, the Affiliated Hospital of Qingdao University, Qingdao, China.; Pokaż więcej
Źródło:: Thoracic cancer [Thorac Cancer] 2024 Mar; Vol. 15 (7), pp. 559-569. Date of Electronic Publication: 2024 Jan 31.
Typ publikacji:: Multicenter Study; Journal Article
MeSH Terms:: Small Cell Lung Carcinoma*
Lung Neoplasms*
Carcinoma, Non-Small-Cell Lung*/drug therapy
Humans ; Neutrophils ; Prognosis ; Retrospective Studies ; Lymphocytes

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: A Population-Based Study of Patients With Small Cell Carcinoma of the Ovary, Hypercalcemic Type, Encompassing a 30-Year Period.
Autorzy:: Blatnik A; From the Departments of Clinical Cancer Genetics (A. Blatnik, Strojnik, Krajc).; Institute of Oncology Ljubljana, Ljubljana, Slovenia; and the Biotechnical Faculty (A. Blatnik, Dragoš).; University of Ljubljana, Ljubljana, Slovenia.
Dragoš VŠ; Molecular Diagnostics (Dragoš, Stegel, Klančar, Novaković).; Institute of Oncology Ljubljana, Ljubljana, Slovenia; and the Biotechnical Faculty (A. Blatnik, Dragoš).; University of Ljubljana, Ljubljana, Slovenia.
Blatnik O; Pathology (O. Blatnik, Drev).; University of Ljubljana, Ljubljana, Slovenia.
Stegel V; Molecular Diagnostics (Dragoš, Stegel, Klančar, Novaković).; University of Ljubljana, Ljubljana, Slovenia.
Klančar G; Molecular Diagnostics (Dragoš, Stegel, Klančar, Novaković).; University of Ljubljana, Ljubljana, Slovenia.
Novaković S; Molecular Diagnostics (Dragoš, Stegel, Klančar, Novaković).; University of Ljubljana, Ljubljana, Slovenia.
Drev P; Pathology (O. Blatnik, Drev).; University of Ljubljana, Ljubljana, Slovenia.
Žagar T; the Epidemiology and Cancer Registry Sector (Žagar).; University of Ljubljana, Ljubljana, Slovenia.
Merlo S; the Divisions of Surgery (Merlo).; Faculty of Medicine (Merlo, Krajc).; University of Ljubljana, Ljubljana, Slovenia.
Škof E; Oncology (Škof, Bojadžiski).; University of Ljubljana, Ljubljana, Slovenia.
Bojadžiski MP; Oncology (Škof, Bojadžiski).; University of Ljubljana, Ljubljana, Slovenia.
Strojnik K; From the Departments of Clinical Cancer Genetics (A. Blatnik, Strojnik, Krajc).; University of Ljubljana, Ljubljana, Slovenia.
Krajc M; From the Departments of Clinical Cancer Genetics (A. Blatnik, Strojnik, Krajc).; Faculty of Medicine (Merlo, Krajc).; University of Ljubljana, Ljubljana, Slovenia.; Pokaż więcej
Źródło:: Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2024 Mar 01; Vol. 148 (3), pp. 299-309.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Small Cell*/genetics
Carcinoma, Small Cell*/pathology
Ovarian Neoplasms*/genetics
Ovarian Neoplasms*/pathology
Hypercalcemia*/genetics
Hypercalcemia*/pathology
Small Cell Lung Carcinoma*
Lung Neoplasms*
Female ; Humans ; Retrospective Studies ; DNA Helicases/genetics ; Nuclear Proteins/genetics ; Transcription Factors/genetics

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Carcinoma"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język